Search
190905_BIAH_Corporate-Booklet_A4_office_print.pdf
office_hours_san_diego_october_2019.pdf
OfficeHours_HearingLoss.pdf
Boehringer_Ingelheim_Company_Profile_2020.pdf
Prevention-and-Treatment-of-Diabetic-and-Cardiovascular-Complications-in-Kenya.pdf
20181130_BI Office Hours-Vienna_flyer_final.pdf
Boehringer_Ingelheim_Company_Profile_2019.pdf
office_hours_london.pdf
focus_on_fibrosis_office_hour_flyer_2021.pdf
grass_roots_office_hours_march31_flyer_2021.pdf
office_hours_vienna.pdf
The Economic Burden of VTE.pdf
Symptoms of VTE.pdf
The Economic Burden of VTE.pdf
open_office_munich_flyer.pdf
US_Office_Hours_2021-10.pdf
Advancing_Anticoagulation_Care_Professor_Levy_Opinion_Piece.pdf
Boehringer_Ingelheim_company_profile_2015.pdf
Boehringer_Ingelheim_Company_Profile_2017.pdf
Ofev®
Ofev® is a prescription medication used to treat people with idiopathic pulmonary fibrosis (IPF) systemic sclerosis-associated interstitial lung disease (SSc-ILD) and other chronic fibrosing interstitial lung diseases with a progressive phenotype
Launch of Frontline flagship store on Tmall
Boehringer Ingelheim launches Frontline flagship store on Tmall to sell selling full range of pet parasiticides.
Groundbeaking of vaccine production center in France
Boehringer Ingelheim breaks ground on its strategic vaccine production center for veterinary public health
Investment of 65 million euro in avian vaccines in France
Boehringer Ingelheim is set to invest almost €65 million in a high-tech building at its Lyon Portes-des-Alpes site in Saint-Priest, France (Rhône), to meet the growing demand worldwide for avian vaccines
Inauguration of new global center for veterinary vaccine R&D
Inauguration of a new global hi-tech centre for biological research and development in Lyon.